Tagomics

Tagomics develops multimodal technologies for precision medicine and diagnostics, presented on its website as a unified platform. Its stated focus areas are drug safety, organ health and oncology, including cancer detection.

The website does not state the company's customers or how it generates revenue. Its open role, a Principal Bioinformatician / Computational Biologist for Drug Safety, is listed under a Computational Technology function.

The company is based at Babraham Research Campus in Cambridge, UK, and describes itself as part of that scientific community. The leadership page lists a CEO, CSO, CTO, CFO and a Director of Computational Technology. The founding year and team size are not stated.

Product: A unified multimodal platform for precision medicine and diagnostics, with focus areas in drug safety, organ health and oncology.